Cited by 215Neuroethics, Human Enhancement, Biomedical InnovationsNeurotransmitter Receptor Influence on BehaviorSleep and Work-Related Fatigue

Modafinil for cognitive neuroenhancement in healthy non-sleep-deprived subjects: A systematic review

Battleday, R.M., Brem, A.-K.·2015·European Neuropsychopharmacology

Abstract

Modafinil is an FDA-approved eugeroic that directly increases cortical catecholamine levels, indirectly upregulates cerebral serotonin, glutamate, orexin, and histamine levels, and indirectly decreases cerebral gamma-amino-butrytic acid levels. In addition to its approved use treating excessive somnolence, modafinil is thought to be used widely off-prescription for cognitive enhancement. However, despite this popularity, there has been little consensus on the extent and nature of the cognitive effects of modafinil in healthy, non-sleep-deprived humans. This problem is compounded by methodological discrepancies within the literature, and reliance on psychometric tests designed to detect cognitive effects in ill rather than healthy populations. In order to provide an up-to-date systematic evaluation that addresses these concerns, we searched MEDLINE with the terms "modafinil" and "cognitive", and reviewed all resultant primary studies in English from January 1990 until December 2014 investigating the cognitive actions of modafinil in healthy non-sleep-deprived humans. We found that whilst most studies employing basic testing paradigms show that modafinil intake enhances executive function, only half show improvements in attention and learning and memory, and a few even report impairments in divergent creative thinking. In contrast, when more complex assessments are used, modafinil appears to consistently engender enhancement of attention, executive functions, and learning. Importantly, we did not observe any preponderances for side effects or mood changes. Finally, in light of the methodological discrepancies encountered within this literature, we conclude with a series of recommendations on how to optimally detect valid, robust, and consistent effects in healthy populations that should aid future assessment of neuroenhancement.

Integrity signals

Registry

Crossref · 10.1016/j.euroneuro.2015.07.028

Cites

74 of 74 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Battleday, R. M., & Brem, A.-K.
Affiliations
  • University of Oxford (GB)
  • Beth Israel Deaconess Medical Center (US)
Corresponding author
Battleday, R.M.
Venue
European Neuropsychopharmacology
Publisher
Elsevier BV
Published
2015-11
Volume
25
Issue
11
Pages
1865-1881
ISSN
0924-977X (ISSN-L)
OpenAlex
W1180171039
Cited by
215
References
74
Citations by year
2026: 10 · 2025: 12 · 2024: 14 · 2023: 14 · 2022: 26 · 2021: 25 · 2020: 23 · 2019: 13 · 2018: 24 · 2017: 20 · 2016: 23 · 2015: 9
FWCI
2.52
Type
journal article
Language
en
Open access
closed
Locations
  • European Neuropsychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Neuroethics, Human Enhancement, Biomedical Innovations
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and Work-Related Fatigue
Keywords
modafinil, cognitive enhancement, executive function, attention, learning and memory, off-label drug use, adverse effects, mood effects, methodological discrepancies
MeSH terms
Modafinil, Benzhydryl Compounds, Cognition, Humans, Nootropic Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review